Management of Advanced Parkinson’s Disease with Infusion Therapies

Management of Advanced Parkinson’s Disease with Infusion Therapies –
Bucharest, Romania – May 26-27, 2017

Management of Advanced Parkinson’s Disease with Infusion Therapies takes place May 26-27, 2017 in Bucharest, Romania.Course Description

This course will provide the theoretical education and practical experience in the management of pump-based treatments for advanced Parkinson’s disease (Levodopa-carbidopa intestinal gel and apomorphine).  The course includes lectures on history, experimental basis, patient selection, effects, side effects and practical management, as well as, interactive workshops on patient selection and practical management.

Recommended Audience

This course is recommended for neurologists, gastroenterologists and Parkinson nurses.

Learning Objectives

At the conclusion of this activity, participants will be able to accomplish the following:

  • Describe the theoretical evidence supporting CDS-based treatment
  • List criteria and demonstrate process for selecting patients for pump-based PD treatment
  • Describe the effects of pump treatments on motor, non-motor symptoms and quality of life
  • Explain and demonstrate management of pump-based therapies
  • Identify possible side effects and complications of pump therapies, including management of these
     
Physician Competencies

The course will address the following physician competencies to increase the effectiveness of the learner:

  • Provide patient-centered care
  • Practice-based learning and improvement
  • Professionalism
  • Improve professional standing
     
CME Accreditation

The 'International Parkinson and Movement Disorder Society' (or) 'Management of Advanced Parkinson’s Disease with Infusion Therapies' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS).

The 'Management of Advanced Parkinson’s Disease with Infusion Therapies' is designated for a maximum of 9 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at
www.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

Venue

Carol Davila University of Medicine and Pharmacy
Prof. Dr. I. Cantacuzion Hall
8: Bulevardul Eroii Sanitari 8, București
050474

Top